These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36773683)

  • 1. A peripherally restricted cannabinoid-1 receptor inverse agonist promotes insulin secretion and protects from cytokine toxicity in human pancreatic islets.
    Ghosh A; Peyot ML; Leung YH; Ravenelle F; Madiraju SRM; Prentki M
    Eur J Pharmacol; 2023 Apr; 944():175589. PubMed ID: 36773683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.
    Wreven E; Ruiz de Adana MS; Hardivillé S; Gmyr V; Kerr-Conte J; Chetboun M; Pasquetti G; Delalleau N; Thévenet J; Coddeville A; Vallejo Herrera MJ; Hinden L; Benavides Espínola IC; Gómez Duro M; Sanchez Salido L; Linares F; Bermúdez-Silva FJ; Tam J; Bonner C; Egan JM; Olveira G; Colomo N; Pattou F; González-Mariscal I
    Diabetologia; 2024 Sep; 67(9):1877-1896. PubMed ID: 38864887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic activation of cannabinoid receptors in vitro does not compromise mouse islet function.
    Vilches-Flores A; Hauge-Evans AC; Jones PM; Persaud SJ
    Clin Sci (Lond); 2013 Apr; 124(7):467-78. PubMed ID: 23078523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exendin-4 overcomes cytokine-induced decreases in gap junction coupling via protein kinase A and Epac2 in mouse and human islets.
    Farnsworth NL; Walter R; Piscopio RA; Schleicher WE; Benninger RKP
    J Physiol; 2019 Jan; 597(2):431-447. PubMed ID: 30412665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of cannabinoid 1 receptor in beta cells protects against high-fat/high-sugar diet-induced beta cell dysfunction and inflammation in murine islets.
    González-Mariscal I; Montoro RA; Doyle ME; Liu QR; Rouse M; O'Connell JF; Santa-Cruz Calvo S; Krzysik-Walker SM; Ghosh S; Carlson OD; Lehrmann E; Zhang Y; Becker KG; Chia CW; Ghosh P; Egan JM
    Diabetologia; 2018 Jun; 61(6):1470-1483. PubMed ID: 29497784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of cannabinoid 1 receptor improves glucose responsiveness in pancreatic beta cells.
    Shin H; Han JH; Yoon J; Sim HJ; Park TJ; Yang S; Lee EK; Kulkarni RN; Egan JM; Kim W
    J Cell Mol Med; 2018 Apr; 22(4):2337-2345. PubMed ID: 29431265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans.
    Liu B; Song S; Ruz-Maldonado I; Pingitore A; Huang GC; Baker D; Jones PM; Persaud SJ
    Diabetes Obes Metab; 2016 Dec; 18(12):1263-1273. PubMed ID: 27561953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Stimulatory Effects of the CB
    Ruz-Maldonado I; Atanes P; Huang GC; Liu B; Persaud SJ
    Cells; 2021 Mar; 10(3):. PubMed ID: 33809893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice.
    McKillop AM; Moran BM; Abdel-Wahab YH; Flatt PR
    Br J Pharmacol; 2013 Nov; 170(5):978-90. PubMed ID: 23992544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans.
    Anderson RL; Randall MD; Chan SL
    Eur J Pharmacol; 2013 Apr; 706(1-3):56-62. PubMed ID: 23499687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M; Ahrén B
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor/factor VIIa signalling promotes cytokine-induced beta cell death and impairs glucose-stimulated insulin secretion from human pancreatic islets.
    Edén D; Siegbahn A; Mokhtari D
    Diabetologia; 2015 Nov; 58(11):2563-72. PubMed ID: 26271343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome.
    Kondo M; Tanabe K; Amo-Shiinoki K; Hatanaka M; Morii T; Takahashi H; Seino S; Yamada Y; Tanizawa Y
    Diabetologia; 2018 Oct; 61(10):2189-2201. PubMed ID: 30054673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
    Winzell MS; Ahrén B
    J Mol Endocrinol; 2008 Feb; 40(2):93-100. PubMed ID: 18234911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells.
    Kim W; Doyle ME; Liu Z; Lao Q; Shin YK; Carlson OD; Kim HS; Thomas S; Napora JK; Lee EK; Moaddel R; Wang Y; Maudsley S; Martin B; Kulkarni RN; Egan JM
    Diabetes; 2011 Apr; 60(4):1198-209. PubMed ID: 21346174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Δ9-Tetrahydrocannabinol Treatment Modifies Insulin Secretion in Pancreatic Islets from Prediabetic Mice Under Hypercaloric Diet.
    Garcia-Luna GM; Bermudes-Contreras JD; Hernández-Correa S; Suarez-Ortiz JO; Diaz-Urbina D; Garfias-Ramirez SH; Vega AV; Villalobos-Molina R; Vilches-Flores A
    Cannabis Cannabinoid Res; 2024 Oct; 9(5):1277-1290. PubMed ID: 37267277
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A GLP‑1 receptor agonist attenuates human islet amyloid polypeptide‑induced autophagy and apoptosis in MIN6 cells.
    Chen X; Huang T; Shi Y; Wang L; Li W; Shen F; Gu X
    Mol Med Rep; 2019 Feb; 19(2):1365-1371. PubMed ID: 30569165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases.
    Lee YS; Jun HS
    Int J Med Sci; 2018; 15(6):603-609. PubMed ID: 29725251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.